CHAUDHURI BHASKAR

CIK 00014586435 companiesIRVINE, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001458643

Recent Transactions

50 trades

Award
Tarsus Pharmaceuticals, Inc.$TARS
Stock Option (right to buy)
2026-06-25+3,837→ 3,837 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2026-06-25+2,417→ 2,417 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2026-06-12+2,954→ 11,654 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2026-06-12−2,954→ 0 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2025-06-13+3,350→ 8,700 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2025-06-13−3,350→ 0 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Stock Option (right to buy)
2025-06-12+4,540→ 4,540 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2025-06-12+2,954→ 2,954 total
Award
Arcutis Biotherapeutics, Inc.$ARQT
Common Stock
2025-06-12+7,609→ 867,826 total
Award
Arcutis Biotherapeutics, Inc.$ARQT
Stock Option (right to buy)
2025-06-12+20,568→ 20,568 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2024-06-24+3,350→ 5,350 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2024-06-24−3,350→ 0 total
Award
Arcutis Biotherapeutics, Inc.$ARQT
Stock Option (right to buy)
2024-06-14+27,052→ 27,052 total
Award
Arcutis Biotherapeutics, Inc.$ARQT
Common Stock
2024-06-14+10,139→ 860,217 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2024-06-13+3,350→ 3,350 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Stock Option (right to buy)
2024-06-13+5,000→ 5,000 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2023-06-22+3,350→ 3,350 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Stock Option (right to buy)
2023-06-22+5,000→ 5,000 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2023-06-16−2,000→ 0 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2023-06-16+2,000→ 2,000 total
Award
Arcutis Biotherapeutics, Inc.$ARQT
Common Stock
2023-05-31+4,375→ 850,078 total
Award
Arcutis Biotherapeutics, Inc.$ARQT
Stock Option (right to buy)
2023-05-31+12,220→ 12,220 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2022-06-16+2,000→ 2,000 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Stock Option (right to buy)
2022-06-16+7,000→ 7,000 total
Award
Arcutis Biotherapeutics, Inc.$ARQT
Common Stock
2022-06-01+4,312→ 845,703 total
Award
Arcutis Biotherapeutics, Inc.$ARQT
Stock Option (Right to Buy)
2022-06-01+11,796→ 11,796 total
Sale
Arcutis Biotherapeutics, Inc.$ARQT
Common Stock
2021-06-25$27.50/sh−6,755→ 841,391 total
Sale
Arcutis Biotherapeutics, Inc.$ARQT
Common Stock
2021-06-24$27.50/sh−729→ 848,146 total
Sale
Arcutis Biotherapeutics, Inc.$ARQT
Common Stock
2021-06-21$27.50/sh−2,516→ 848,875 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Stock Option (right to buy)
2021-06-15+10,000→ 10,000 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Stock Option (right to buy)
2021-06-15+10,000→ 10,000 total
Award
Arcutis Biotherapeutics, Inc.$ARQT
Stock Option (Right to Buy)
2021-06-09+13,391→ 13,391 total
Sale
Arcutis Biotherapeutics, Inc.$ARQT
Common Stock
2021-06-01$27.50/sh−10,000→ 851,391 total
Sale
Arcutis Biotherapeutics, Inc.$ARQT
Common Stock
2021-04-20$28.53/sh−1,280→ 861,391 total
Sale
Arcutis Biotherapeutics, Inc.$ARQT
Common Stock
2021-04-20$27.99/sh−8,720→ 862,671 total
Sale
Arcutis Biotherapeutics, Inc.$ARQT
Common Stock
2021-04-20$27.99/sh−8,720→ 862,671 total
Sale
Arcutis Biotherapeutics, Inc.$ARQT
Common Stock
2021-04-20$28.53/sh−1,280→ 861,391 total
Sale
Arcutis Biotherapeutics, Inc.$ARQT
Common Stock
2021-03-22$30.77/sh−5,008→ 876,383 total
Sale
Arcutis Biotherapeutics, Inc.$ARQT
Common Stock
2021-03-22$31.43/sh−4,992→ 871,391 total
Sale
Arcutis Biotherapeutics, Inc.$ARQT
Common Stock
2021-02-22$35.97/sh−2,789→ 881,391 total
Sale
Arcutis Biotherapeutics, Inc.$ARQT
Common Stock
2021-02-22$35.34/sh−7,211→ 884,180 total
Sale
Arcutis Biotherapeutics, Inc.$ARQT
Common Stock
2021-02-01$33.25/sh−9,949→ 891,391 total
Sale
Arcutis Biotherapeutics, Inc.$ARQT
Common Stock
2021-01-29$27.50/sh−51→ 901,340 total
Award
Teligent, Inc.
Stock Option
2021-01-04+2,000→ 2,000 total
Award
Arcutis Biotherapeutics, Inc.$ARQT
Stock Option (Right to Buy)
2020-02-27+24,000→ 24,000 total
Conversion
Arcutis Biotherapeutics, Inc.$ARQT
Common Stock
2020-02-04+49,981→ 49,981 total
Conversion
Arcutis Biotherapeutics, Inc.$ARQT
Series A Preferred Stock
2020-02-04−49,981→ 0 total
Conversion
Arcutis Biotherapeutics, Inc.$ARQT
Common Stock
2020-02-04+37,486→ 901,391 total
Conversion
Arcutis Biotherapeutics, Inc.$ARQT
Series A Preferred Stock
2020-02-04−37,486→ 0 total
Award
Teligent, Inc.
Stock Option
2020-01-02+20,000→ 20,000 total

Companies

Recent Filings

Address

C/O TARSUS PHARMACEUTICALS, INC. 17700 LAGUNA CANYON ROAD, FLOOR 4

IRVINE, CA, 92618

View on SEC.gov